Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-03 Sale | 2025-04-07 12:30 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 17,210 | $11.97 | $205,932 | 3,124,472 (Indirect) | View |
| 2025-04-01 Sale | 2025-04-03 5:22 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 46,723 | $12.34 | $576,754 | 3,141,682 (Indirect) | View |
| 2025-03-31 Sale | 2025-04-01 4:21 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 48,623 | $12.58 | $611,677 | 3,188,405 (Indirect) | View |
| 2025-03-27 Sale | 2025-03-31 12:07 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 36,524 | $13 | $474,961 | 3,237,028 (Indirect) | View |
| 2025-03-24 Sale | 2025-03-25 11:47 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 2,329 | $13.21 | $30,766 | 3,273,552 (Indirect) | View |
| 2025-02-26 Sale | 2025-02-27 10:09 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 200 | $13.62 | $2,724 | 3,275,881 (Indirect) | View |
| 2025-02-13 Sale | 2025-02-18 1:09 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 100 | $13.88 | $1,388 | 3,276,081 (Indirect) | View |
| 2025-02-12 Sale | 2025-02-13 7:45 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 36,536 | $13.75 | $502,370 | 3,276,181 (Indirect) | View |
| 2025-02-10 Sale | 2025-02-12 1:00 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 62,743 | $13.89 | $871,709 | 3,312,717 (Indirect) | View |
| 2025-02-03 Sale | 2025-02-05 10:39 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 5,911 | $14.04 | $83,013 | 3,375,460 (Indirect) | View |
| 2025-01-30 Sale | 2025-02-03 3:30 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 36,978 | $14.21 | $525,274 | 3,381,371 (Indirect) | View |
| 2025-01-29 Sale | 2025-01-30 10:57 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 11,674 | $14.12 | $164,837 | 3,418,349 (Indirect) | View |
| 2024-08-23 Purchase | 2024-08-27 2:46 pm | abrdn Life Sciences Investors | HQL | Maher Bill Director | 650 | $15.37 | $9,991 | 1,715 (Indirect) | View |
| 2024-07-16 Purchase | 2024-07-18 2:56 pm | abrdn Life Sciences Investors | HQL | DiMartino Rose Director | 1,000 | $15.53 | $15,530 | 1,000 (Direct) | View |
| 2024-06-26 Purchase | 2024-06-27 11:22 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 100 | $14.07 | $1,407 | 3,429,991 (Indirect) | View |
| 2024-06-24 Purchase | 2024-06-25 5:36 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 13,812 | $14.08 | $194,473 | 3,429,891 (Indirect) | View |
| 2024-06-12 Purchase | 2024-06-14 1:59 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 10,867 | $13.83 | $150,326 | 3,416,079 (Indirect) | View |
| 2024-06-10 Purchase | 2024-06-11 5:03 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 11,743 | $13.72 | $161,098 | 3,405,212 (Indirect) | View |
| 2024-06-06 Purchase | 2024-06-10 08:45 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 13,361 | $13.78 | $184,081 | 3,393,469 (Indirect) | View |
| 2024-06-04 Purchase | 2024-06-05 5:09 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 59,440 | $13.61 | $809,222 | 3,380,108 (Indirect) | View |
| 2024-05-31 Purchase | 2024-06-03 5:11 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 21,369 | $13.29 | $283,994 | 3,320,668 (Indirect) | View |
| 2024-05-28 Purchase | 2024-05-31 3:08 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 47,416 | $13.14 | $623,176 | 3,299,299 (Indirect) | View |
| 2024-05-23 Purchase | 2024-05-23 7:41 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 1,303 | $13.5 | $17,591 | 3,251,883 (Indirect) | View |
| 2024-05-15 Purchase | 2024-05-17 12:34 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 34,755 | $14.19 | $493,173 | 3,250,580 (Indirect) | View |
| 2024-05-10 Purchase | 2024-05-14 1:50 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 57,862 | $13.86 | $801,967 | 3,215,825 (Indirect) | View |
| 2024-05-08 Purchase | 2024-05-10 10:31 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 28,359 | $13.76 | $390,256 | 3,157,963 (Indirect) | View |
| 2024-05-06 Purchase | 2024-05-07 5:07 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 60,874 | $13.74 | $836,126 | 3,129,604 (Indirect) | View |
| 2024-05-01 Purchase | 2024-05-02 4:50 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 26,526 | $13.46 | $356,929 | 3,068,730 (Indirect) | View |
| 2024-04-30 Purchase | 2024-05-01 10:23 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 16,573 | $13.13 | $217,603 | 3,042,204 (Indirect) | View |
| 2024-04-26 Purchase | 2024-04-29 4:54 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 120,304 | $13 | $1,563,952 | 3,025,602 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-06-18 3:18 pm | N/A N/A | abrdn Life Sciences Investors | HQL | Nichols Rebecca Suzanne Director of Adviser Director | 0 | $0 | 0 (Direct) | View |